continu view ci top pick best idea think stori
rel straightforward oper execut drive multipl expans solid
guidanc met consensu reflect strong growth servic indic
busi well posit sustain growth continu think share
attract valu adj ep
encourag strong result posit momentum
carri paricularli pleas compani
custom retent rate toward upper bound consid solid
pbm retent rate retent rate coupl estim script
prime win organ growth reflect strong sell season
net-new win expect adj script growth slightli midpoint
ci guidanc think growth could acceler given innov pharmaci
solut ci bring market embarc safeguardrx
believ ci must buy back signific number share ahead order
divestitur neutral adj ep estim group disabl
adj oper incom pre-tax worth ep base full
share repurchas contempl ci guidanc
assum share repurchas
given repurchas far track roughli in-lin estim
anoth full year share repurchas project would increas
capac current buy-back program
would reduc weight averag share count assum
deal close mid-to-l estim would reduc adj net incom
base lower full year share count estim adj ep would
rang
els equal share repurchas assumpt would increas year-end
debt/capit ratio unaffect basi assum
increment debt repay addit full year estim
would lower debt/capit within ci target rang note combin
share repurchas increment debt repay estim reflect full deploy
after-tax proce ci expect receiv sale group disabl
adj ep estim unchang respect
although updat quarterli estim reflect ci expect earn
cadenc rais price target impli share trade
estim vs current multipl price target impli
upsid share
pleas see page report import disclosur
posit share ci believ acquisit esrx posit compani
succeed evolv healthcar landscap stand-alone basi ci carv
strong posit market particularli aso recent result demonstr abil
deliv strong result led critic compani spend billion
acquir esrx reflect rel depress valuat compar peer
believ unwarr believ investor may give enough credit near-
term growth opportun yet outlin beyond million cost synergi
greater purchas scale esrx ci posit full-risk aso
market believ strateg valu esrx even potenti near-
term accret lie long-term posit market shift toward greater care
coordin value-bas care
grow y/i
oper earn grow y/i
stronger expect medic custom
integr challeng lower
expect synergi esrx deal
global health servic compani subsidiari offer medic dental
disabl life accid insur relat product servic
product servic offer employ group select
intern market offer supplement health life accid insur product
intern health care coverag servic busi government non-
government organ individu decemb acquir
script largest pharmaci benefit manag script servic includ
drug util review formulari manag diseas manag medic drug
data analysi servic medic inform manag servic oper five
segment integr medic intern market oper
corpor
compani report cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
compani report cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom incom adjust oper share outstand fulli net incom reconcili net chang servic pre-tax incom end decemb cowen
compani report cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom loss adjust incom adjust oper share outstand fulli net incom reconcili amort acquir intang realiz gain chang y/i invest cost benefit servic pre-tax incom cowen
compani report cowen compani
receiv current held polici acquisit tax asset asset account insur contracthold servic cost expens held insur contracthold tax liabil non-curr account non-controlling equitycommon paid comprehens treasuri stock sharehold liabil sharehold liquid ratio current receiv claim payabl structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
compani report cowen compani
invest gain incom extinguish chang asset liabil net non-oper effect account polici acquisit servic cost payabl accru expens oper net cash equip purchas invest repay debt common common foreign currenc rate chang cash cash increas decreas end decemb cowen
compani report cowen compani
invest gain loss incom tax benefit extinguish chang asset liabil net non-oper effect account polici acquisit servic cost payabl accru expens oper invest sold fix matur equiti matur repay fix matur equiti sale matur purchas fix matur equiti primarili short-term equip net cash invest interest credit contracthold deposit benefit payment contracthold deposit chang short-term debt long-term proce issuanc long-term common common financ foreign currenc rate chang cash cash increas decreas cash classifi within asset held increas decreas end decemb cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
integr esrx anoth potenti risk particularli compani eventu move
ci live onto esrx platform also begin march began transit
membership pbm ingeniorx support disrupt could
impact ci note esrx tsa run
transit work move would need negoti
potenti propos hh regard futur rebat could impact ci
would expect potenti impact headlin risk vs meaning impact
remain chanc administr could propos sweep broad new
